Cequa Reporting























































I heard from a credible source that they don’t want it to get any better. Which makes sense...when’s the last time you heard from management or marketing re: ideas of how to improve the volume of Rxs counted? **crickets**
 
























I’m sure we all know a certain Detroit manager thats working on this. She can’t possibly not be number 1. There has to be a mistake . Meanwhile the rest of us are out here busting our asses
 






I’m sure we all know a certain Detroit manager thats working on this. She can’t possibly not be number 1. There has to be a mistake . Meanwhile the rest of us are out here busting our asses


What is so funny (and true) about this is she was so nice at her previous company. Goes to Sun and becomes a raging (fill in the blank)
 






Listen, I’m not sure the issue is credit for processed scripts, as much as it is the discrepancy in formulary status at the Medicaid, Medicare, and commercial level in relation to geography.

This is not to say that the reps who are crushing it, aren’t doing well—they’re obviously doing a fantastic job. It is to say that there is a pretty clear correlation between the market access landscape within each territory and the corresponding script performance.

Hopefully, when quotas are created for upcoming quarters territories are segmented with formularies in mind... better yet, maybe we will have some formulary wins at the national level.
 






Ok i don’t know who wrote this but if you are worried about or selling to formulary access you really have no idea what you are doing.. i spend very little time talking about that.
 






Ok i don’t know who wrote this but if you are worried about or selling to formulary access you really have no idea what you are doing.. i spend very little time talking about that.


Obviously, formulary discussions are not the way to sell the product. However, coverage does impact pull through and long term success. Think about it: over the course of a couple weeks Dr. Jones prescribes 20 Rxs of Cequa and after a stack of PAs and step edits only 2 patients end up filling their prescriptions... do you think Dr. Jones begins using more or less Cequa?

Salesforces help generate awareness and drive demand... but we are only one component of a successful product within the marketplace. If this weren’t true, why would Novartis have field access managers on their payroll, why does Sun have market access folks at home office on their payroll, and why is there such a large correlation between preferential Medicaid/Medicare/commercial coverage and territory launch performance?
 






Obviously, formulary discussions are not the way to sell the product. However, coverage does impact pull through and long term success. Think about it: over the course of a couple weeks Dr. Jones prescribes 20 Rxs of Cequa and after a stack of PAs and step edits only 2 patients end up filling their prescriptions... do you think Dr. Jones begins using more or less Cequa?

Salesforces help generate awareness and drive demand... but we are only one component of a successful product within the marketplace. If this weren’t true, why would Novartis have field access managers on their payroll, why does Sun have market access folks at home office on their payroll, and why is there such a large correlation between preferential Medicaid/Medicare/commercial coverage and territory launch performance?

Instead of asking silly rhetorical questions just answer them. Who needs these riddles?